A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
Clinical trial NCT06148948 · COMPLETED
Trial details
- NCT number
- NCT06148948
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2024-05-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.